Crinetics Pharmaceuticals, Inc. (CRNX)
41.76
+1.01
(+2.48%)
USD |
NASDAQ |
May 06, 16:00
41.76
0.00 (0.00%)
After-Hours: 16:10
Crinetics Pharmaceuticals Market Cap : 4.372B for May 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amneal Pharmaceuticals, Inc. | 4.284B |
| Plus Therapeutics, Inc. | 41.24M |
| Nektar Therapeutics | 1.471B |
| Madrigal Pharmaceuticals, Inc. | 12.36B |
| Terns Pharmaceuticals, Inc. | 6.111B |
Market Cap Related Metrics
| PS Ratio | 510.34 |
| PEG Ratio | -0.2520 |
| Price to Book Value | 4.407 |
| Price | 41.76 |
| Earnings Yield | -11.84% |
| PEGY Ratio | -0.2520 |